Evaluation of the Safety of Primaquine in Combination With Artemether-lumefantrine in Glucose-6-phosphate Dehydrogynase Deficient Males With an Asymptomatic Malaria Infection in Burkina Faso (SAFEPRIM)
Phase of Trial: Phase II/III
Latest Information Update: 12 Feb 2016
Price : $35 *
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Primaquine
- Indications Malaria
- Focus Therapeutic Use
- Acronyms SAFEPRIM
- 29 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Mar 2015 Planned End Date changed from 1 Jan 2015 to 1 Sep 2015, according to to ClinicalTrials.gov record.
- 31 Mar 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Jul 2015, according to to ClinicalTrials.gov record.